The blood thinner drug Xarelto (Rivaroxiban) has been involved in hundreds of lawsuits from patients who experienced internal bleeding and other adverse effects while taking the new generation anti-coagulant drug.
But a new caution has been issued, warning physicians that Xarelto is dangerous for patients with chronic or late stage kidney disease.
The new warning was recently issued by the American Heart Association in conjunction with the American College of Cardiology and the American Society of Thoracic Surgeons. These medical professionals were recently developing new guidelines for the treatment of patients who suffer from irregular heartbeat, a condition known as non-valvular atrial fibrillation.
The physicians have now issued a caution, warning against the use of Xarelto in patients with chronic or late-stage kidney disease or renal failure. These individuals are at higher risk of developing blood clots and experiencing a stroke or heart attack, but Xarelto should not be used due to the body’s decreased ability to process and flush out the drug.
As a result, dangerously high levels of Xarelto can arise in these patients, resulting in an increased risk of internal bleeding.
This group of medical experts say that Xarelto should not be prescribed to patients with kidney failure or late-stage chronic kidney disease (CKD), also known as Stage 5 CKD.
What is Xarelto?
Manufactured by Johnson & Johnson subsidiary Janssen Pharmaceuticals and Bayer AG, Xarelto is prescribed to patients with non-valvular atrial fibrillation, pulmonary embolism and deep-vein thrombosis or DVT. It’s also prescribed to patients who’ve undergone knee or hip replacement surgeries to prevent post-surgical blood clot formation.
The new generation anti-coagulant drug is designed to thin the blood, which subsequently reduces the risk of forming blood clots and suffering a stroke. But in some cases, Xarelto is dangerous because it can cause uncontrolled bleeding. There have even been reports of dangerous blood clots – a condition that the drug is designed to prevent.
Uncontrolled Internal Bleeding and Xarelto
Xarelto has been linked to many different forms of uncontrolled bleeding, including stomach bleeds, colon bleeding, eye bleeding, brain bleeds and renal bleeding. Multiple studies have been performed into the Xarelto internal bleeding risks and some have revealed a risk that’s up to 200% higher when compared to other anti-coagulant drugs, like Warfarin.
Notably, there is no effective reversal method or antidote for Xarelto, which makes internal bleeding incidents all the more dangerous.
The oldest blood thinner drug on the market, Warfarin/Coumadin, can be reversed with infusions of Vitamin K. Pradaxa, another new generation blood thinner medication, can be reversed through emergency dialysis. But even emergency dialysis will not help a patient who’s suffering uncontrolled internal bleeding while on Xarelto.
Xarelto was originally marketed as an alternative to Coumadin, as it doesn’t require the routine blood testing that’s required for Coumadin. But many claim they were never informed of the drug’s risks and the fact that there is no reversal agent or antidote available for the drug.
Legal Action for Xarelto Patients
Hundreds of Xarelto lawsuits have been filed in recent months, as a result of uncontrolled bleeding incidents and even fatalities that have occurred as a result of Xarelto usage.
A small number of lawsuits have been settled by Xarelto’s manufacturers, but hundreds more are still in the court system. In fact, the large quantity of Xarelto lawsuits has led officials to create a multi- district litigation (MDL), which streamlines the pre-trial processes, such as discovery and evidence sharing.
The federal Xarelto MDL lawsuits are now in the Eastern District of Louisiana, where Judge Eldon Fallon is overseeing the proceedings. The courts are currently in the midst of selecting bellwether cases, which will soon be tried, thereby providing the plaintiffs and defendants with insight into the overall viability of the hundreds of other MDL cases.
If you or a loved one experienced uncontrolled bleeding while on Xarelto, you have legal rights! You may be eligible to receive financial compensation for your financial losses, medical bills, pain and suffering and beyond.
Contact the experienced legal team at The Meldofsky Firm today for a free, no-obligation evaluation of your case. Call immediately (877) 274-8672.